(Q67973680)

English

The antiparkinson efficacy of deprenyl derives from transient improvement that is likely to be symptomatic

scientific article published on 01 December 1992

Statements

The antiparkinson efficacy of deprenyl derives from transient improvement that is likely to be symptomatic (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit